XML 43 R27.htm IDEA: XBRL DOCUMENT v3.22.2.2
STOCKHOLDERS’ EQUITY AND STOCK-BASED COMPENSATION (Tables)
 9 Months Ended
Sep. 24, 2022
Equity [Abstract]  
SCHEDULE OF NON-VESTED RESTRICTED STOCK ACTIVITY

Restricted stock activity for the nine months ended September 24, 2022 was as follows:

       Weighted Average 
   Shares   Grant Fair Value 
Balance, December 25, 2021   2,077,592   $2.90 
Granted   996,500    1.32 
Forfeited   (239,950)   2.56 
Vested   (353,843)   2.19 
Balance, September 24, 2022   2,480,299   $2.40 
SCHEDULE OF STOCK-BASED COMPENSATION EXPENSE

The following table summarizes stock-based compensation expense within each of the categories below as it relates to non-vested restricted common stock awards for the three and nine months ended September 24, 2022 and September 25, 2021 (no tax benefits were recognized):

 

   2022   2021   2022   2021 
   Three Months Ended   Three Months Ended  

Nine months Ended

   Nine months Ended 
   September 24,
2022		   September 25,
2021		   September 24,
2022		   September 25,
2021		 
Cost of product revenues  $41,373   $37,674   $119,754   $206,247 
Research and development   111,928    180,152    367,654    395,217 
Selling, general and administrative   144,247    424,358    883,246    3,165,395 
Total  $297,548   $642,184   $1,370,654   $3,766,859